The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
The Elusive P2X7 Macropore
Open accessAbstract
ATP, which is released under pathological conditions and is considered a damage-associated molecular pattern (DAMP), activates P2X7 receptors (P2X7Rs), trimeric plasma membrane ion channels selective for small cations. P2X7Rs are partners in NOD-like receptor containing a pyrin (NLRP3) inflammasome activation and promoters of tumor cell growth. P2X7R overstimulation triggers the ATP-dependent opening of a nonselective plasma membrane pore, known as a 'macropore', which allows fluxes of large hydrophilic molecules. The pathophysiological functions of P2X7R are thought to be dependent on activation of this conductance pathway, yet its molecular identity is unknown. Recent reports show that P2X7R permeability to organic solutes is an early and intrinsic property of the channel itself. A better understanding of P2X7R-dependent changes in plasma membrane permeability will allow a rationale development of novel anti-inflammatory and anticancer drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The P2X7 receptor is a trimeric ionotropic receptor that belongs to the P2X family of purinergic receptors, presenting low affinity for ATP (EC50 around 0.3–1.8 mM) and, under prolonged stimulation, can form pores allowing the passage of large hydrophilic molecules [62–64].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [64]
Citations
Cites
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919
Muñoz-Planillo, R., Kuffa, P., Martínez-Colón, G. J., Smith, B. L., Rajendiran, T. M., & Núñez, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.016 · Cited by 2,167
The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739
Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor
Pelegrı́n, P., & Surprenant, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601378 · Cited by 1,490
The P2X7 Receptor in Infection and Inflammation
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.020 · Cited by 1,267
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J. M., Perregaux, D. G., Stam, E. J., Petrushova, N., Koller, B. H., Griffiths, R., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 924
Yang, D., He, Y., Muñoz-Planillo, R., Liu, Q., & Núñez, G. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.009 · Cited by 622
Pathophysiology and Therapeutic Potential of Purinergic Signaling
Burnstock, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.5 · Cited by 618
Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics
Bannas, P., Hambach, J., & Koch-Nolte, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01603 · Cited by 572
Ischemia Opens Neuronal Gap Junction Hemichannels
Thompson, R. J., Zhou, N., & MacVicar, B. A. (2006) · Science · doi:10.1126/science.1126241 · Cited by 560
Flagged first, then by citations
Cited by
Sorted by citations
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment
Virgilio, F. D., Sarti, A. C., Falzoni, S., Marchi, E. D., & Adinolfi, E. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0037-0 · Cited by 748
Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy
Muzio, L., Viotti, A., & Martino, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.742065 · Cited by 581
Zhou, Y., Fei, M., Zhang, G., Liang, W., Lin, W., Wu, Y., Piskol, R., Ridgway, J. B., McNamara, E., Huang, H., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.01.014 · Cited by 406
Biological responses to physicochemical properties of biomaterial surface
Rahmati, M., Silva, E. A., Reseland, J. E., Heyward, C. A., & Haugen, H. J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00103a · Cited by 409
Update of P2X receptor properties and their pharmacology: IUPHAR Review 30
Illés, P., Müller, C. E., Jacobson, K. A., Grütter, T., Nicke, A., Fountain, S. J., Kennedy, C., Schmalzing, G., Jarvis, M. F., Stojilković, S. S., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15299 · Cited by 327
Self-citationMicroglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293
Extracellular ATP: A Feasible Target for Cancer Therapy
Vultaggio-Poma, V., Sarti, A. C., & Virgilio, F. D. (2020) · Cells · doi:10.3390/cells9112496 · Cited by 259
How microglia sense and regulate neuronal activity
Umpierre, A. D., & Wu, L. (2021) · Glia · doi:10.1002/glia.23961 · Cited by 237
Regulation of Microglial Functions by Purinergic Mechanisms in the Healthy and Diseased CNS
Illés, P., Rubini, P., Ulrich, H., Zhao, Y., & Tang, Y. (2020) · Cells · doi:10.3390/cells9051108 · Cited by 249
P2X7 Interactions and Signaling – Making Head or Tail of It
Kopp, R., Krautloher, A., Ramírez-Fernández, A., & Nicke, A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00183 · Cited by 217
Extracellular nucleotides and nucleosides as signalling molecules
Giuliani, A. L., Sarti, A. C., & Virgilio, F. D. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.11.006 · Cited by 230
Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody
Kaczmarek-Hájek, K., Zhang, J., Kopp, R., Grosche, A., Rissiek, B., Saul, A., Bruzzone, S., Engel, T., Jooss, T., Durner, A., et al. (2018) · eLife · doi:10.7554/elife.36217 · Cited by 218
The Concise Guide to PHARMACOLOGY 2023/24: Ion channels
Alexander, S. P. H., Mathie, A. A., Peters, J. A., Veale, E. L., Striessnig, J., Kelly, E., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16178 · Cited by 204
Kong, H., Zhao, H., Chen, T., Song, Y., & Cui, Y. T. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04786-w · Cited by 189
P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
Lara, R., Adinolfi, E., Harwood, C. A., Philpott, M. P., Barden, J. A., Virgilio, F. D., & McNulty, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00793 · Cited by 174
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145
Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target
You, R., He, X., Zeng, Z., Zhan, Y., Xiao, Y., & Xiao, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.841732 · Cited by 150
P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases
Illés, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175996 · Cited by 145
Microglia and the Purinergic Signaling System
Calovi, S., Mut-Arbona, P., & Sperlágh, B. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.12.021 · Cited by 143
ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity
Silva-Vilches, C., Ring, S., & Mahnke, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02581 · Cited by 127
Extracellular ATP: A powerful inflammatory mediator in the central nervous system
Virgilio, F. D., Vultaggio-Poma, V., Falzoni, S., & Giuliani, A. L. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109333 · Cited by 126
A central role for P2X7 receptors in human microglia
Janks, L., Sharma, C. V. R., & Egan, T. M. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1353-8 · Cited by 114
Astroglia-Derived ATP Modulates CNS Neuronal Circuits
Illés, P., Burnstock, G., & Tang, Y. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.09.006 · Cited by 107
P2X7 Receptor: A Potential Therapeutic Target for Depression?
Deussing, J. M., & Arzt, E. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.07.005 · Cited by 97
P2RX7 Purinoceptor as a Therapeutic Target—The Second Coming?
Young, C., & Górecki, D. C. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00248 · Cited by 97
The P2X7 Receptor in Microglial Cells Modulates the Endolysosomal Axis, Autophagy, and Phagocytosis
Campagno, K. E., & Mitchell, C. H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.645244 · Cited by 94
Modulation of innate and adaptive immunity by P2X ion channels
Virgilio, F. D., Sarti, A. C., & Grassi, F. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.026 · Cited by 95
ATP-Gated P2X Receptor Channels: Molecular Insights into Functional Roles
Schmid, R., & Evans, R. J. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114259 · Cited by 92
Recent insights into the regulatory networks of NLRP3 inflammasome activation
Weber, A. N. R., Bittner, Z., Shankar, S., Liu, X., Chang, T.-H., Jin, T., & Tapia‐Abellán, A. (2020) · Journal of Cell Science · doi:10.1242/jcs.248344 · Cited by 85
Inherent P2X7 Receptors Regulate Macrophage Functions during Inflammatory Diseases
Ren, W.-J., Rubini, P., Tang, Y., Engel, T., & Illés, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010232 · Cited by 70
Regulation of P2X7 receptor expression and function in the brain
Jimenez-Mateos, E. M., Smith, J., Nicke, A., & Engel, T. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.12.008 · Cited by 80
Pathological ATPergic Signaling in Major Depression and Bipolar Disorder
Illés, P., Verkhratsky, A., & Tang, Y. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00331 · Cited by 78
Ectonucleotidases in Acute and Chronic Inflammation
Giuliani, A. L., Sarti, A. C., & Virgilio, F. D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.619458 · Cited by 83
Role of P2X7 Receptors in Immune Responses During Neurodegeneration
Oliveira-Giacomelli, Á., Petiz, L. L., Andrejew, R., Turrini, N., Silva, J. B., Sack, U., & Ulrich, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.662935 · Cited by 68
Territo, P. R., & Zarrinmayeh, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.617036 · Cited by 73
Pegoraro, A., Marchi, E. D., & Adinolfi, E. (2021) · Cells · doi:10.3390/cells10010189 · Cited by 67
Structural and Functional Features of the P2X4 Receptor: An Immunological Perspective
Kanellopoulos, J., Almeida-da-Silva, C. L. C., Boudinot, S. R., & Ojcius, D. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.645834 · Cited by 69
Involvement of P2X7 receptors in chronic pain disorders
Ren, W., & Illés, P. (2021) · Purinergic Signalling · doi:10.1007/s11302-021-09796-5 · Cited by 62
Structural basis for the functional properties of the P2X7 receptor for extracellular ATP
Jiang, L., Caseley, E. A., Muench, S. P., & Roger, S. (2021) · Purinergic Signalling · doi:10.1007/s11302-021-09790-x · Cited by 61
Oliveira-Giacomelli, Á., M. Albino, C., de Souza, H. D. N., Corrêa-Velloso, J., de Jesus Santos, A. P., Baranova, J., & Ulrich, H. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00476 · Cited by 60
Astrocytic and Oligodendrocytic P2X7 Receptors Determine Neuronal Functions in the CNS
Zhao, Y., Tang, Y., & Illés, P. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.641570 · Cited by 60
da Silva, H. B., Wang, H.-G., Qian, L. J., Hogquist, K., & Jameson, S. (2019) · Journal of Immunology · doi:10.4049/jimmunol.1801613 · Cited by 60
Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells
Virgilio, F. D., Jiang, L., Roger, S., Falzoni, S., Sarti, A. C., Vultaggio-Poma, V., Chiozzi, P., & Adinolfi, E. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.07.043 · Cited by 59
Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma
Zanoni, M., Sarti, A. C., Zamagni, A., Cortesi, M., Pignatta, S., Arienti, C., Tebaldi, M., Sarnelli, A., Romeo, A., Bartolini, D., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04526-0 · Cited by 62
Pegoraro, A., Orioli, E., Marchi, E. D., Salvestrini, V., Milani, A., Virgilio, F. D., Curti, A., & Adinolfi, E. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03058-9 · Cited by 58
ATP release during seizures – A critical evaluation of the evidence
Beamer, E. H., Conte, G., & Engel, T. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.12.021 · Cited by 62
Agonists and Antagonists for Purinergic Receptors
Müller, C. E., Baqi, Y., & Namasivayam, V. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9717-6_3 · Cited by 55
Zhou, Y., Zhang, C., Duan, J., Li, Q., Yang, H., Sun, C., Zhang, J., Luo, X., & Liu, S. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109596 · Cited by 51
Wilkaniec, A., Cieślik, M., Murawska, E., Babiec, L., Gąssowska-Dobrowolska, M., Pałasz, E., Jęśko, H. M., & Adamczyk, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113959 · Cited by 51
Tozzi, M., Hansen, J. B., & Novak, I. (2019) · Acta Physiologica · doi:10.1111/apha.13360 · Cited by 49
Pleiotropic Roles of P2X7 in the Central Nervous System
Kanellopoulos, J. M., & Delarasse, C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00401 · Cited by 48
The P2X7 receptor: a new therapeutic target in Alzheimer’s disease
Illés, P., Rubini, P., Huang, L., & Tang, Y. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1575811 · Cited by 50
Carluccio, M., Ziberi, S., Zuccarini, M., Giuliani, P., Caciagli, F., Iorio, P. D., & Ciccarelli, R. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09703-4 · Cited by 52
Novel biologics targeting the P2X7 ion channel
Koch‐Nolte, F., Eichhoff, A. M., Pinto-Espinoza, C., Schwarz, N., Schäfer, T., Menzel, S., Haag, F., Demeules, M., Gondé, H., & Adriouch, S. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.03.001 · Cited by 51
ATP-Gated P2X7 Receptors Require Chloride Channels To Promote Inflammation in Human Macrophages
Janks, L., Sprague, R. S., & Egan, T. M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801101 · Cited by 45
P2X7R antagonists in chronic stress-based depression models: a review
von Mücke-Heim, I.-A., Ries, C., Urbina-Treviño, L., & Deussing, J. M. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01306-3 · Cited by 47
P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3
Feng, W., Yang, X. Q., Wang, L., Wang, R., Yang, F., Wang, H., Liu, X., Ren, Q., Zhang, Y., Zhu, X., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.243360 · Cited by 44
Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?
Benzaquen, J., Heeke, S., Hreich, S. J. D., Douguet, L., Marquette, C., Hofman, P. M., & Vouret‐Craviari, V. (2019) · Biomedical Journal · doi:10.1016/j.bj.2019.05.007 · Cited by 46
Ziberi, S., Zuccarini, M., Carluccio, M., Giuliani, P., Ricci‐Vitiani, L., D, R. P. M., Caciagli, F., Iorio, P. D., & Ciccarelli, R. (2019) · Cells · doi:10.3390/cells9010085 · Cited by 41
Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases
Zheng, H., Liu, Q., Zhou, S., Luo, H., & Zhang, W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1345625 · Cited by 43
Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment
Scarpellino, G., Genova, T., & Munaron, L. (2019) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892814666190116122256 · Cited by 36
Role of the P2X7 receptor in in vitro and in vivo glioma tumor growth
Bergamin, L. S., Capece, M., Salaro, E., Sarti, A. C., Falzoni, S., Pereira, M. S. L., Bastiani, M. A. D., Scholl, J. N., Battastini, A. M. O., & Virgilio, F. D. (2019) · Oncotarget · doi:10.18632/oncotarget.27106 · Cited by 36
Purinergic signaling: Diverse effects and therapeutic potential in cancer
Kaur, J., & Dora, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1058371 · Cited by 36
To Inhibit or Enhance? Is There a Benefit to Positive Allosteric Modulation of P2X Receptors?
Stokes, L., Bidula, S. M., Bibič, L., & Allum, E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00627 · Cited by 37
Magni, L., Bouazzi, R., Olmedilla, H. H., Petersen, P. S. S., Tozzi, M., & Novak, I. (2021) · Cells · doi:10.3390/cells10081928 · Cited by 35
The P2X7 receptor and pannexin-1 are involved in glucose-induced autocrine regulation in β-cells
Tozzi, M., Larsen, A. T., Lange, S. C., Giannuzzo, A., Andersen, M. N., & Novak, I. (2018) · Scientific Reports · doi:10.1038/s41598-018-27281-9 · Cited by 33
Nurkhametova, D., Kudryavtsev, I. V., Гусельникова, В. В., Серебрякова, М. К., Giniatullina, R., Wojciechowski, S., Töre, F., Rizvanov, A. A., Koıstınaho, J., Malm, T., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00045 · Cited by 35
Liu, X., Li, Y., Huang, L., Kuang, Y., Wu, X., Ma, X., Zhao, B., & Lan, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1450704 · Cited by 39
Targeting P2X7 receptors as a means for treating retinal disease
Fletcher, E. L., Wang, A. Y., Jobling, A. I., Rutar, M., Greferath, U., Gu, B. J., & Vessey, K. A. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.029 · Cited by 32
Dissection of P2X4 and P2X7 Receptor Current Components in BV-2 Microglia
Trang, M., Schmalzing, G., Müller, C. E., & Markwárdt, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228489 · Cited by 32
Self-citationA Mechanism-Based Approach to P2X7 Receptor Action
Uğur, M., & Uğur, Ö. (2019) · Molecular Pharmacology · doi:10.1124/mol.118.115022 · Cited by 32
The purinergic P2X7 ion channel receptor — a ‘repair’ receptor in bone
Jørgensen, N. R. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.016 · Cited by 31
P2RX7 at the Host-Pathogen Interface of Infectious Diseases
Soare, A. Y., Freeman, T. L., Min, A. K., Malik, H. S., Osota, E. O., & Swartz, T. H. (2021) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00055-20 · Cited by 31
Cancer Metabostemness and Metabolic Reprogramming via P2X7 Receptor
Rabelo, I. L. A., Arnaud-Sampaio, V. F., Adinolfi, E., Ulrich, H., & Lameu, C. (2021) · Cells · doi:10.3390/cells10071782 · Cited by 30
Purinergic Signaling and Inflammasome Activation in Psoriasis Pathogenesis
Ferrari, D., Casciano, F., Secchiero, P., & Reali, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179449 · Cited by 31
Modulation of Microglial Function by ATP-Gated P2X7 Receptors: Studies in Rat, Mice and Human
Tewari, M., Michalski, S. A., & Egan, T. M. (2024) · Cells · doi:10.3390/cells13020161 · Cited by 36
Exploring the Role of P2X Receptors in Alzheimer’s Disease
Godoy, P. A., Ramírez-Molina, O., & Fuentealba, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01330 · Cited by 31
Ion Channels as New Attractive Targets to Improve Re-Myelination Processes in the Brain
Cherchi, F., Bulli, I., Venturini, M., Pugliese, A. M., & Coppi, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147277 · Cited by 27
Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star?
Schmidt, S., Isaak, A., & Junker, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021374 · Cited by 28
P2X7 receptor antagonists for the treatment of systemic inflammatory disorders
Gelin, C. F., Bhattacharya, A., & Letavic, M. A. (2020) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2019.11.002 · Cited by 28
Yin, Y., Wei, L., Caseley, E. A., Lopez‐Charcas, O., Wei, Y., Li, D., Muench, S. P., Roger, S., Wang, L., & Jiang, L. (2023) · Medicinal Research Reviews · doi:10.1002/med.21952 · Cited by 25
To inhibit or to boost the ATP/P2RX7 pathway to fight cancer—that is the question
Hreich, S. J. D., Benzaquen, J., Hofman, P. M., & Vouret‐Craviari, V. (2021) · Purinergic Signalling · doi:10.1007/s11302-021-09811-9 · Cited by 27
Aria, H., Rezaei, M., Nazem, S., Daraei, A., Nikfar, G., Mansoori, B., Bahmanyar, M., Tavassoli, A., Vakil, M. K., & Mansoori, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.947885 · Cited by 26
Animal Models for the Investigation of P2X7 Receptors
Sluyter, R., Adriouch, S., Fuller, S. J., Nicke, A., Sophocleous, R. A., & Watson, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098225 · Cited by 28
Geraghty, N. J., Watson, D., & Sluyter, R. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.12.001 · Cited by 26
Loureiro, A. V., Moura-Neto, L. I., Martins, C. S., Silva, P. I. M., Lopes, M. B. S., Leitão, R. F. D. C., Coelho‐Aguiar, J. M., Moura‐Neto, V., Warren, C. A., Costa, D. V. D. S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956340 · Cited by 26
From lead to clinic: A review of the structural design of P2X7R antagonists
Zhang, R., Li, N., Zhao, M., Tang, M., Jiang, X., Cai, X., Ye, N., Su, K., Peng, J., Zhang, X., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115234 · Cited by 26
Untangling Macropore Formation and Current Facilitation in P2X7
Cevoli, F., Arnould, B., Peralta, F. A., & Grütter, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310896 · Cited by 26
P2X7 Variants in Pathophysiology
Pegoraro, A., Grignolo, M., Ruo, L., Ricci, L., & Adinolfi, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126673 · Cited by 25
Purinergic receptors and the inflammatory response mediated by lipids
Alarcón‐Vila, C., Pizzuto, M., & Pelegrı́n, P. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.02.004 · Cited by 25
P2X7 Receptor in Hematological Malignancies
Marchi, E. D., Pegoraro, A., & Adinolfi, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645605 · Cited by 25
Cáceres, F. T., Gaspari, T. A., Hossain, M. A., & Samuel, C. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137074 · Cited by 27
Kozlovskiy, S., Pislyagin, Е. А., Menchinskaya, E. S., Chingizova, E. A., Sabutski, Y. E., Полоник, С. Г., Николаевна, Л. Г., & Aminin, D. L. (2023) · Toxins · doi:10.3390/toxins15010047 · Cited by 25
Manfredini, M., Giuliani, A. L., Ruina, G., Gafà, R., Bosi, C., Zoppas, E., Virgilio, F. D., & Bettoli, V. (2019) · Dermatology · doi:10.1159/000502026 · Cited by 25
The Multifaceted Role of P2X7R in Microglia and Astrocytes
Bedetta, M., Pizzo, P., & Lia, A. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04502-y · Cited by 28
Carluccio, M., Zuccarini, M., Ziberi, S., Giuliani, P., Morabito, C., Mariggiò, M. A., Lonardo, M. T., Adinolfi, E., Orioli, E., Iorio, P. D., et al. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09883-6 · Cited by 24
Wang, K., Sun, M., Juan, Z., Zhang, J., Sun, Y., Wang, G., Wang, C., Li, Y., Kong, W., Fan, L., et al. (2022) · Behavioural Neurology · doi:10.1155/2022/3777351 · Cited by 24
Purinergic receptors modulators: An emerging pharmacological tool for disease management
Mahmood, A., & Iqbal, J. (2022) · Medicinal Research Reviews · doi:10.1002/med.21888 · Cited by 24
Bergamin, L. S., Penolazzi, L., Lambertini, E., Falzoni, S., Sarti, A. C., Molle, C. M., Gendron, F., BONIS, P. D., Virgilio, F. D., & Piva, R. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29891 · Cited by 23
eATP/P2X7R Axis: An Orchestrated Pathway Triggering Inflammasome Activation in Muscle Diseases
Panicucci, C., Raffaghello, L., Bruzzone, S., Baratto, S., Principi, E., Minetti, C., Gazzerro, E., & Bruno, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175963 · Cited by 28
Metadata
- Authors
- Di Virgilio, F., Schmalzing, G., & Markwardt, F.
- Affiliations
- RWTH Aachen University (DE)
- Venue
- Trends in Cell Biology
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 28
- Issue
- 5
- Pages
- 392-404
- ISSN
- 0962-8924 (ISSN-L)
- OpenAlex
- W2787249947
- Cited by
- 279
- References
- 96
- Citations by year
- 2026: 23 · 2025: 22 · 2024: 41 · 2023: 44 · 2022: 31 · 2021: 30 · 2020: 33 · 2019: 37 · 2018: 17
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Trends in Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, cc-by-nc-nd)
- Funders
- Italian Association for Cancer Research (13025, 18581)
- Ministry of Health of Italy (RF-2011-02348435)
- University of Ferrara
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- P2X7 receptor, ATP, plasma membrane permeability, NLRP3 inflammasome, damage-associated molecular patterns, ion channel conductance, anti-inflammatory agents, anticancer agents
- MeSH terms
- Alarmins, NLR Family, Pyrin Domain-Containing 3 Protein, Adenosine Triphosphate, Cell Membrane Permeability, Humans, Neoplasms, Signal Transduction, Cell Proliferation, Receptors, Purinergic P2X7, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review